Folic acid-containing compound metabolic process

pathway activity — cross-omics
GO:0006760Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Folic acid-containing compound metabolic process pathway is significantly associated with the RNA expression of multiple genes, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are CLEC12A, PLEK, and PLA2G7, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Folic acid-containing compound metabolic process activity versus CLEC12A in BRCA (Pearson r = 0.34).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCACLEC12A →+0.615+0.148.001.00434
BRCAPLEK →+0.797+0.167<.001.00233
BRCAPLA2G7 →+0.747+0.140<.001.00133
BRCAUSP6NL →+0.493+0.156<.001<.00133
BRCASCIMP →+0.386+0.124<.001.00533
LSCCCLEC4D →+0.512+0.211.001<.00133
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0006760 vs CLEC12A — BRCA

Per-sample scatter of Folic acid-containing compound metabolic process activity vs CLEC12A in BRCA.

Explore this scatter interactively →

Exploration